Presymptomatic Neuromuscular Disorders Disclosed Following Statin Treatment
- 24 July 2006
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 166 (14), 1519-1524
- https://doi.org/10.1001/archinte.166.14.1519
Abstract
It is well recognized that statins affect muscular tissue adversely and that their use is associated with clinically important myositis, rhabdomyolysis, mild elevation of serum creatine kinase (CK) levels, myalgias, muscle weakness, muscle cramps, and persistent myalgias or serum CK level elevations after statin treatment is discontinued. The association between statins and the disclosure of presymptomatic metabolic myopathy is another underrated phenomenon related to statin therapy that was recently recognized in rare cases. The purpose of this report is to provide additional support for this association and to report other neuromuscular disorders that have also been seen following statin intake. The present case series illustrates that statins may act as unmasking agents in asymptomatic patients with a latent neuromuscular disorder. Thus, it may be postulated that statin intake may be a sufficient insult to precipitate neuromuscular symptoms and substantially increase muscle enzymes in presymptomatic patients with an abnormal neuromuscular substrate. In conclusion, muscular symptoms or increased serum CK levels persisting after statin treatment discontinuation should alert the clinician to pursue further diagnostic evaluations for the detection of potential underlying neuromuscular diseases.Keywords
This publication has 15 references indexed in Scilit:
- Statin‐disclosed acid maltase deficiencyJournal of Internal Medicine, 2005
- Statin‐Associated Peripheral Neuropathy: Review of the LiteraturePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- Current overview of statin-induced myopathyAmerican Journal Of Medicine, 2004
- The case of stainless statins.Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2003
- Statin-Associated Myopathy with Normal Creatine Kinase LevelsAnnals of Internal Medicine, 2002
- The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatmentAtherosclerosis, 1999
- Lovastatin increases exercise-induced skeletal muscle injuryMetabolism, 1997
- The effect of Simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscleThe American Journal of Cardiology, 1996
- Simvastatin-induced rhabdomyolysis followed by a melas syndromeAmerican Journal Of Medicine, 1993
- Myotonia induced with clofibrate in ratsZeitschrift für Neurologie, 1978